Identification of SMYD2 as a candidate diagnostic and prognostic biomarker for gastric cancer
These findings established SMYD2 is a major oncogene that can serve as a candidate diagnostic and prognostic biomarker for GC.
Authors
- Qingzhi Liu (ORCID: https://orcid.org/0000-0003-2621-9222)
- Cuiping Mao (ORCID: https://orcid.org/0000-0002-1094-6102)
- Chuanxi Zhao
- Shanshan Ding (ORCID: https://orcid.org/0000-0003-1935-694X)
- Dongmei Li (ORCID: https://orcid.org/0000-0003-1401-5716)
- Shujun Zhang (ORCID: https://orcid.org/0000-0001-5699-2676)
- Wenjing Shang
- Sichao Wang (ORCID: https://orcid.org/0000-0002-2286-178X)
Institutions
- Second Hospital of Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3389/fonc.2025.1617971
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00